Another study in favor of an oncogenic role for the GR demonstrates that GR signaling causes cancer cells to acquire a reversible dormant state which is characterized by a resistance to multiple anticancer drugs and an upregulation of insulin-like growth factor 1 receptor survival signaling vulnerability to inhibitors. The gene discussed is NR3C1; the disease is cancer.